Mar 09, 2019
Challenge Massive IVIG spending forced a health system in the Northwest to question whether using seven different brands made clinical and financial sense.
Solution Lumere reviewed over 200 published studies to compare safety and efficacy across brands. The evidence showed that six brands had similarly broad utility across patient populations. Standardizing to one of the six would provide similar patient outcomes while cutting costs.
Impact Standardizing 80% of IVIG volume to one brand will yield a projected $480,000 in annual savings.
Challenge A West Coast academic medical center (AMC) needed to implement use restrictions to combat rampant off-label utilization.
Solution Lumere’s review of the evidence showed that, of the AMC’s top ten uses for IVIG, only five were supported by evidence, four were conditionally supported and one was not supported.
Impact Service line working groups used Lumere’s guidance on appropriate utilization and dosing to create and implement rigorous policies to standardize care and reduce off-label use.
Service line working groups used Lumere’s guidance on appropriate utilization and dosing to create and implement rigorous policies to standardize care and reduce off-label use.
annual savings in IVIG spend
IVIG volume standardized to one brand
of top ten uses of IVIG impacted by guidelines
© Lumere All rights reserved